title: Increase in trimethoprim-sulphamethoxazole (co-trimoxazole) resistance at Chris Hani Baragwanath Hospital, Soweto, in the AIDS era.
authors.forename: Heather H
authors.initials: HH
authors.lastname: Crewe-Brown
authors.forename: Maria P
authors.initials: MP
authors.lastname: Reyneke
authors.forename: Manikant
authors.initials: M
authors.lastname: Khoosal
authors.forename: Piet J
authors.initials: PJ
authors.lastname: Becker
authors.forename: Alan S
authors.initials: AS
authors.lastname: Karstaedt
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000453:epidemiology; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D045363:Pneumocystis carinii / Q000187:drug effects; D011020:Pneumonia, Pneumocystis / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D012307:Risk Factors; D013019:South Africa / Q000453:epidemiology; D014123:Toxoplasmosis / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*; D014481:United States / Q000453:epidemiology
chemical_list: D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination